Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Definitive copromotion agreement for cilostazol signed by Otsuka and Pharmacia & Upjohn

April 29, 1999

Aggrenox unanimously recommended for approval for stroke indication

April 29, 1999

Merck & Co. discovers new series with antithrombin effects

April 23, 1999

SmithKline Beecham synthesizes pharmaceutically active integrin receptor antagonists

April 23, 1999

Merck identifies a nonpeptide, linearly minimized, centrally constrained gpIIb/IIIa antagonist

April 22, 1999

News from FASEB: novel factor Xa inhibitor presented by DuPont Pharmaceuticals

April 22, 1999

European Commission approves novel albumin-free treatment for hemophilia A

April 19, 1999

NovoSeven reaches the U.S. hemophilia market

April 15, 1999

FDA approves Fragmin for DVT after hip replacement surgery

April 13, 1999

Potent, selective peptidomimetic thrombin inhibitors emerge from U.S.-Canadian partnership

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...